Model
Edge
EyePoint Pharmaceuticals Inc.
0002013623
Filing Type
144
Filing Date
4/16/2026
Updated
4/17/26, 2:36 PM
Filing
144
Earnings Release
Exhibits
144
Notice of Proposed Sale of Securities